HK1039898A1 - 含有擬交感神經胺鹽的不適合非法使用的組合物 - Google Patents
含有擬交感神經胺鹽的不適合非法使用的組合物Info
- Publication number
- HK1039898A1 HK1039898A1 HK02101442.0A HK02101442A HK1039898A1 HK 1039898 A1 HK1039898 A1 HK 1039898A1 HK 02101442 A HK02101442 A HK 02101442A HK 1039898 A1 HK1039898 A1 HK 1039898A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compositions
- amine salts
- illegal use
- sympathomimetic amine
- salts unsuitable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9971298P | 1998-09-10 | 1998-09-10 | |
PCT/US1999/020708 WO2000015261A1 (en) | 1998-09-10 | 1999-09-09 | Compositions comprising sympathomimetic amine salts unsuitable for illegal use |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1039898A1 true HK1039898A1 (zh) | 2002-05-17 |
Family
ID=22276270
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK02101442.0A HK1039898A1 (zh) | 1998-09-10 | 2002-02-26 | 含有擬交感神經胺鹽的不適合非法使用的組合物 |
Country Status (22)
Country | Link |
---|---|
US (4) | US6359011B1 (zh) |
EP (1) | EP1112089A1 (zh) |
JP (1) | JP2002524534A (zh) |
KR (1) | KR20010075021A (zh) |
CN (1) | CN1201822C (zh) |
AR (1) | AR032730A1 (zh) |
AU (2) | AU771194B2 (zh) |
BR (1) | BR9913575A (zh) |
CA (1) | CA2339354A1 (zh) |
CO (1) | CO5280050A1 (zh) |
CR (1) | CR6106A (zh) |
GT (1) | GT199900148A (zh) |
HK (1) | HK1039898A1 (zh) |
HN (1) | HN1999000156A (zh) |
MY (1) | MY117971A (zh) |
NZ (1) | NZ510012A (zh) |
PA (1) | PA8481601A1 (zh) |
PE (1) | PE20001034A1 (zh) |
SV (1) | SV1999000148A (zh) |
TW (1) | TW550071B (zh) |
UY (1) | UY25702A1 (zh) |
WO (1) | WO2000015261A1 (zh) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GT199900148A (es) * | 1998-09-10 | 2001-02-28 | Desnaturalizantes para las sales aminas simpaticomimeticas. | |
AU7105501A (en) * | 2000-07-17 | 2002-01-30 | Yamanouchi Pharma Co Ltd | Pharmaceutical composition improved in peroral absorbability |
US7736670B2 (en) * | 2000-11-30 | 2010-06-15 | Vectura Limited | Method of making particles for use in a pharmaceutical composition |
ITMI20021074A1 (it) * | 2002-05-20 | 2003-11-20 | Actimex S R L | Composizione ternaria comprendente una sostanza attiva e processo di comacinazione per la sua preparazione |
US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
US7201920B2 (en) | 2003-11-26 | 2007-04-10 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse of opioid containing dosage forms |
US20050220877A1 (en) * | 2004-03-31 | 2005-10-06 | Patel Ashish A | Bilayer tablet comprising an antihistamine and a decongestant |
DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
DE102004045037A1 (de) * | 2004-09-15 | 2006-03-16 | Basf Ag | Pharmazeutische Darreichungsformen mit erschwerter Extrahierbarkeit eines Sympathomimetikums aus der Darreichungsform |
DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
ATE493118T1 (de) * | 2006-01-19 | 2011-01-15 | Dow Global Technologies Inc | Biologisch wirksame zusammensetzung mit ethylcellulose |
US9238073B2 (en) | 2006-04-12 | 2016-01-19 | Wyeth Llc | Pharmaceutical composition containing sympathomimetic amine salt and co-distillable additive |
US8273798B2 (en) * | 2007-06-04 | 2012-09-25 | Shear Kershman Laboratories | Tamper resistant lipid-based oral dosage form for opioid agonists |
AU2008280801B2 (en) * | 2007-07-23 | 2014-03-06 | Kingsway Pharmaceuticals Inc. | Therapeutic formulations for the treatment of cold and flu-like symptoms |
MX2010004178A (es) | 2007-10-19 | 2010-05-03 | Otsuka Pharma Co Ltd | Preparacion farmaceutica solida de tipo matriz. |
BR112012001466A2 (pt) | 2009-07-22 | 2020-08-11 | Grünenthal GmbH | forma de dosagem resistente à falsificação para opioides sensíveis à oxidação, seu processo de fabricação, e embalagem |
US8901113B2 (en) * | 2009-09-30 | 2014-12-02 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse |
CA2839123A1 (en) | 2011-07-29 | 2013-02-07 | Grunenthal Gmbh | Tamper-resistant tablet providing immediate drug release |
MX348054B (es) | 2011-07-29 | 2017-05-25 | Gruenenthal Gmbh | Tableta a prueba de alteracion que proporciona liberacion inmediata del farmaco. |
WO2013036567A2 (en) * | 2011-09-07 | 2013-03-14 | Johnson Brent A | Methods, compositions, and compounds for the reduction of illegal methamphetamine production |
WO2013089986A1 (en) * | 2011-12-12 | 2013-06-20 | Product And Technology Partners Llc | Improved denaturants for sympathomimetic amines |
CA2880163A1 (en) * | 2012-08-01 | 2014-02-06 | Acura Pharmaceuticals, Inc. | Stabilization of one-pot methamphetamine synthesis systems |
AU2013352162B2 (en) | 2012-11-30 | 2018-08-16 | Acura Pharmaceuticals, Inc. | Self-regulated release of active pharmaceutical ingredient |
AU2014284333B2 (en) * | 2013-07-03 | 2017-03-16 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse |
KR20160031526A (ko) | 2013-07-12 | 2016-03-22 | 그뤼넨탈 게엠베하 | 에틸렌-비닐 아세테이트 중합체를 함유하는 템퍼 내성 투여형 |
BR112016010482B1 (pt) | 2013-11-26 | 2022-11-16 | Grünenthal GmbH | Preparação de uma composição farmacêutica em pó por meio de criomoagem |
AU2015237721B2 (en) | 2014-03-26 | 2018-04-26 | Sun Pharma Advanced Research Company Ltd. | Abuse deterrent immediate release coated reservoir solid dosage form |
WO2017040607A1 (en) | 2015-08-31 | 2017-03-09 | Acura Pharmaceuticals, Inc. | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
US10842750B2 (en) * | 2015-09-10 | 2020-11-24 | Grünenthal GmbH | Protecting oral overdose with abuse deterrent immediate release formulations |
TW202002957A (zh) | 2018-02-09 | 2020-01-16 | 德商歌林達有限公司 | 包含轉化抑制劑之麻黃素及其衍生物之抗損壞調配物 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3169092A (en) | 1963-09-26 | 1965-02-09 | Richardson Merrell Inc | Stabilization of amines by tartrazine and bisulfite |
US3546142A (en) * | 1967-01-19 | 1970-12-08 | Amicon Corp | Polyelectrolyte structures |
US3773920A (en) * | 1971-07-14 | 1973-11-20 | Nikken Chemicals Co Ltd | Sustained release medicinal composition |
GB1593261A (en) | 1976-07-23 | 1981-07-15 | Inveresk Res Int | Controlled release suppository |
RO68771A2 (ro) * | 1976-08-25 | 1980-08-15 | Intreprinderea De Medicamente,Ro | Unguent antipruriginos si sicativ |
SU1146046A1 (ru) | 1983-11-11 | 1985-03-23 | Центральный Ордена Ленина Институт Усовершенствования Врачей | Состав дл ретракции десны |
US4493827A (en) | 1983-11-14 | 1985-01-15 | Ronald Valle | Method of inducing sleep |
US4601894A (en) * | 1985-03-29 | 1986-07-22 | Schering Corporation | Controlled release dosage form comprising acetaminophen, pseudoephedrine sulfate and dexbrompheniramine maleate |
US4657757A (en) | 1985-03-29 | 1987-04-14 | Schering Corporation | Controlled release dosage form comprising acetaminophen, pseudoephedrine sulfate and dexbrompheniramine maleate |
US4800087A (en) * | 1986-11-24 | 1989-01-24 | Mehta Atul M | Taste-masked pharmaceutical compositions |
US5026560A (en) * | 1987-01-29 | 1991-06-25 | Takeda Chemical Industries, Ltd. | Spherical granules having core and their production |
US4894239A (en) | 1987-06-02 | 1990-01-16 | Takeda Chemical Industries, Ltd. | Sustained-release preparation and production thereof |
ZA904021B (en) | 1989-11-24 | 1991-02-27 | Van Der Linde Leon | Slimming preparations |
CA2068402C (en) | 1991-06-14 | 1998-09-22 | Michael R. Hoy | Taste mask coatings for preparation of chewable pharmaceutical tablets |
US5407686A (en) | 1991-11-27 | 1995-04-18 | Sidmak Laboratories, Inc. | Sustained release composition for oral administration of active ingredient |
US5518730A (en) * | 1992-06-03 | 1996-05-21 | Fuisz Technologies Ltd. | Biodegradable controlled release flash flow melt-spun delivery system |
EP1166801A1 (en) | 1993-06-04 | 2002-01-02 | Warner-Lambert Company | Preparations containing silicon dioxide to improve the taste thereof |
US5543405A (en) * | 1993-10-22 | 1996-08-06 | Keown; Wendy J. | Composition and method for weight reduction and long term management of obesity |
AUPM814994A0 (en) | 1994-09-14 | 1994-10-06 | Sterling Winthrop Inc. | Codeine-containing formulations |
US5529783A (en) | 1994-12-19 | 1996-06-25 | Mcneil-Ppc, Inc. | Rotor granulation and coating of acetaminophen, pseudoephedrine, chlorpheniramine, and, optionally dextromethorphan |
US5626878A (en) | 1995-01-10 | 1997-05-06 | Warner Lambert Company | Reduction of electrostatic forces between magnesium trisilicate adsorbates |
CA2250010C (en) | 1996-04-10 | 2008-06-10 | Warner-Lambert Company | Denaturants for sympathomimetic amine salts |
GT199900148A (es) * | 1998-09-10 | 2001-02-28 | Desnaturalizantes para las sales aminas simpaticomimeticas. |
-
1999
- 1999-09-07 GT GT199900148A patent/GT199900148A/es unknown
- 1999-09-08 US US09/391,739 patent/US6359011B1/en not_active Expired - Lifetime
- 1999-09-08 MY MYPI99003873A patent/MY117971A/en unknown
- 1999-09-09 AU AU59157/99A patent/AU771194B2/en not_active Ceased
- 1999-09-09 HN HN1999000156A patent/HN1999000156A/es unknown
- 1999-09-09 CR CR6106A patent/CR6106A/es not_active Application Discontinuation
- 1999-09-09 CN CNB998107565A patent/CN1201822C/zh not_active Expired - Fee Related
- 1999-09-09 PE PE1999000908A patent/PE20001034A1/es not_active Application Discontinuation
- 1999-09-09 SV SV1999000148A patent/SV1999000148A/es not_active Application Discontinuation
- 1999-09-09 CA CA002339354A patent/CA2339354A1/en not_active Abandoned
- 1999-09-09 CO CO99057123A patent/CO5280050A1/es not_active Application Discontinuation
- 1999-09-09 PA PA19998481601A patent/PA8481601A1/es unknown
- 1999-09-09 BR BR9913575-2A patent/BR9913575A/pt not_active Application Discontinuation
- 1999-09-09 KR KR1020017003081A patent/KR20010075021A/ko not_active Application Discontinuation
- 1999-09-09 JP JP2000569845A patent/JP2002524534A/ja active Pending
- 1999-09-09 AR ARP990104527A patent/AR032730A1/es unknown
- 1999-09-09 EP EP99946837A patent/EP1112089A1/en not_active Withdrawn
- 1999-09-09 WO PCT/US1999/020708 patent/WO2000015261A1/en not_active Application Discontinuation
- 1999-09-09 UY UY25702A patent/UY25702A1/es not_active Application Discontinuation
- 1999-09-09 NZ NZ510012A patent/NZ510012A/xx unknown
- 1999-09-10 TW TW088115613A patent/TW550071B/zh not_active IP Right Cessation
-
2001
- 2001-11-20 US US09/996,438 patent/US20020082304A1/en not_active Abandoned
-
2002
- 2002-02-26 HK HK02101442.0A patent/HK1039898A1/zh unknown
-
2004
- 2004-06-18 AU AU2004202702A patent/AU2004202702B2/en not_active Ceased
-
2005
- 2005-07-20 US US11/186,681 patent/US20050256194A1/en not_active Abandoned
-
2006
- 2006-06-02 US US11/445,967 patent/US20060216268A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NZ510012A (en) | 2002-11-26 |
US20020082304A1 (en) | 2002-06-27 |
WO2000015261A1 (en) | 2000-03-23 |
HN1999000156A (es) | 2003-08-01 |
CA2339354A1 (en) | 2000-03-23 |
PE20001034A1 (es) | 2000-10-18 |
KR20010075021A (ko) | 2001-08-09 |
US20050256194A1 (en) | 2005-11-17 |
JP2002524534A (ja) | 2002-08-06 |
TW550071B (en) | 2003-09-01 |
US6359011B1 (en) | 2002-03-19 |
AU5915799A (en) | 2000-04-03 |
CO5280050A1 (es) | 2003-05-30 |
CN1316911A (zh) | 2001-10-10 |
AR032730A1 (es) | 2003-11-26 |
PA8481601A1 (es) | 2001-04-30 |
US20060216268A1 (en) | 2006-09-28 |
MY117971A (en) | 2004-08-30 |
CR6106A (es) | 2003-12-05 |
CN1201822C (zh) | 2005-05-18 |
BR9913575A (pt) | 2001-05-22 |
GT199900148A (es) | 2001-02-28 |
SV1999000148A (es) | 2000-09-11 |
AU2004202702B2 (en) | 2007-11-22 |
EP1112089A1 (en) | 2001-07-04 |
AU2004202702A1 (en) | 2004-07-15 |
AU771194B2 (en) | 2004-03-18 |
UY25702A1 (es) | 1999-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1039898A1 (zh) | 含有擬交感神經胺鹽的不適合非法使用的組合物 | |
HUP0101619A3 (en) | Adjuvant compositions | |
HUP0101804A3 (en) | Adjuvant composition and methods for its use | |
HUP0100472A3 (en) | Novel amines as pharmaceutical agents | |
IL148406A0 (en) | Pharmaceutical tramadol salts | |
HK1040394A1 (en) | N-substituted 2-cyanopyrrolidines | |
HUP9700589A3 (en) | Extended release formulation containing venlaflaxine hydrochloride | |
PL343065A1 (en) | Vaccine composition | |
DE69723248D1 (de) | Vergällungsstoffe für sympathomimetische aminsalze | |
PL350163A1 (en) | Adjuvant composition | |
BR0013131B1 (pt) | "processo para a preparação de boehmita microcristalina contendo um adtivo homogeneamente dispersado". | |
GB2338490B (en) | Polishing composition | |
IL138178A0 (en) | Identifiable marking compositions and methods | |
EG24178A (en) | Calcilytic compounds | |
GB9809025D0 (en) | Amine dispersants | |
HUP0302930A3 (en) | Process for the preparation n-(substituted phenyl)-3-alkyl-,aryl- and heteroaryl-sulfonil-2-hydroxy-2-alkyl- and haloalkylpropanamide compounds | |
GB9810529D0 (en) | Intumescent composition | |
EP1414425A4 (en) | AMINE COMPOUNDS AND NEUROTRANSMITTER REUPTAKE INHIBITION | |
PL342295A1 (en) | Paroxetin salts | |
HUP0302919A3 (en) | Method for the preparation of (e)-n-(6,6-dimethyl-2-hepten-4-ynyl)-n-methyl-1-naphtalenemethanamine | |
GB9801870D0 (en) | Vaccine composition | |
PL349775A1 (en) | New morpholinobenzamide salts | |
IL143808A0 (en) | Oral vaccine against diarrhea | |
HUP0104707A3 (en) | Cleaning agent for hard surfaces | |
HK1054551B (zh) | 製備(3-氯-4-氟苯基)-胺化合物的方法 |